MENU

5 things to watch on the ASX on Tuesday

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) had a soft start to the week on Monday. The benchmark index fought back from its early decline to finish the day 2 points lower at 6,141.7 points.

Will the market perform better on Tuesday? Here are five things to watch:

ASX futures pointing higher.

According to the latest SPI futures, the Australian share market is tipped to edge higher at the open. Futures are pointing to a one point rise this morning despite a reasonably positive night of trade on Wall Street. Overnight the Dow Jones slid 0.2% lower, but the S&P 500 rose 0.2% and the Nasdaq increased 0.3%.

Oil prices mixed.

Oil prices were mixed again overnight. According to Bloomberg, the WTI crude oil price fell 0.35% to US$67.51 a barrel, but the Brent crude oil price rose 0.7% to US$77.36 a barrel. This was the fourth session in a row that U.S. crude oil prices had fallen. Mixed supply signals appear to be weighing on U.S. oil prices right now.

Royal Commission continues.

The Royal Commission continues on Tuesday with its focus on insurance. On Monday Clearview Wealth Ltd (ASX: CVW) admitted it may have broken the law up to 303,000 times by cold calling people to sell life insurance.

Shares going ex-dividend.

Retailer Adairs Ltd (ASX: ADH), Brambles Limited (ASX: BXB), biotech giant CSL Limited (ASX: CSL), media company News Corp (ASX: NWS), and aged care operator Regis Healthcare Ltd (ASX: REG) are just five of a number of shares going ex-dividend this morning and likely to edge lower at the open.

Ramsay rated as a sell.

According to a note out of Goldman Sachs which looks at the Australian healthcare sector, the broker has declared Ramsay Health Care Limited (ASX: RHC) shares as a sell with a $49.00 price target. The broker thinks investors should focus on ResMed Inc. (ASX: RMD) instead. It has a buy rating and $16.70 price target on the sleep treatment company’s shares.

Here are three top shares to watch this week. I'm tipping them for big things in FY 2019.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Atlassian.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!